Submissions for variant NM_021625.4(TRPV4):c.947G>A (p.Arg316His) (rs387906905)

Minimum review status:		Collection method:
Minimum conflict level:
		ClinVar version:

Total submissions: 7

Download table as spreadsheet

Submitter	RCV	SCV	Clinical significance	Condition	Last evaluated	Review status	Method	Comment
Molecular Diagnostics Lab,Nemours Alfred I. duPont Hospital for Children	RCV000497541	SCV000590825	likely pathogenic	not provided	2016-04-05	criteria provided, single submitter	clinical testing
Invitae	RCV000023430	SCV000767281	pathogenic	Charcot-Marie-Tooth disease axonal type 2C	2017-12-09	criteria provided, single submitter	clinical testing	This sequence change replaces arginine with histidine at codon 316 of the TRPV4 protein (p.Arg316His). The arginine residue is moderately conserved and there is a small physicochemical difference between arginine and histidine. This variant is not present in population databases (ExAC no frequency). This variant has been reported in individuals affected with Charcot-Marie-Tooth disease type 2C (CMT2C), scapuloperoneal spinal muscular atrophy (SPSMA), distal hereditary motor neuropathy (dHMN), and arthrogryposis multiplex congenita (AMC) (PMID: 21288981, 24789864, 24319099). In one affected individual it was reported to occur de novo (PMID: 21288981) and in an affected family it was reported to segregate with disease (PMID: 24319099). ClinVar contains an entry for this variant (Variation ID: 30473). Experimental studies have shown that this missense change leads to cell death that can be reversed by a TRPV4 agonist (PMID: 21288981). A different missense substitution at this codon (p.Arg316Cys) has been determined to be pathogenic (PMID: 20037587, 20037588, 24789864, 21454511). This suggests that the arginine residue is critical for TRPV4 protein function and that other missense substitutions at this position may also be pathogenic. For these reasons, this variant has been classified as Pathogenic.
Centre for Mendelian Genomics,University Medical Centre Ljubljana	RCV001197411	SCV001368140	pathogenic	Clubfoot; EMG abnormality; Lower limb amyotrophy; Fatty replacement of skeletal muscle	2016-01-01	criteria provided, single submitter	clinical testing	This variant was classified as: Uncertain significance. This variant was detected in heterozygous state.
OMIM	RCV000023430	SCV000044721	pathogenic	Charcot-Marie-Tooth disease axonal type 2C	2011-03-08	no assertion criteria provided	literature only
GeneReviews	RCV000202476	SCV000148066	pathogenic	Neuromuscular disease	2014-04-02	no assertion criteria provided	literature only
Centre for Mendelian Genomics,University Medical Centre Ljubljana	RCV000415397	SCV000492580	pathogenic	Clubfoot; EMG abnormality; Lower limb amyotrophy	2016-03-18	no assertion criteria provided	clinical testing
Genesis Genome Database	RCV000856932	SCV000999496	uncertain significance	Charcot-Marie-Tooth disease	2019-08-14	no assertion criteria provided	research

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.